I. Demonstration and purification of an endogenous benzodiazepine from the mammalian brain with a monoclonal antibody to benzodiazepines
- 16 November 1986
- journal article
- Published by Elsevier in Life Sciences
- Vol. 39 (21), 1927-1936
- https://doi.org/10.1016/0024-3205(86)90316-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Diazepam-Binding Inhibitor: A Neuropeptide Located in Selected Neuronal Populations of Rat BrainScience, 1985
- Multiple signals in gabaergic transmission: Pharmacological consequencesNeuropharmacology, 1984
- Morphological diversity of immunocytochemically identified GABA neurons in the monkey sensory-motor cortexJournal of Neurocytology, 1983
- Solubilization of Brain Benzodiazepine Receptors with a Zwitterionic Detergent: Optimal Preservation of Their Functional Interaction with the GABA ReceptorsJournal of Neurochemistry, 1983
- Benzodiazepine receptors: are there endogenous ligands in the brain?Trends in Pharmacological Sciences, 1981
- Identification of an endogenous peptide-ligand for the benzodiazepine receptorBiochemical and Biophysical Research Communications, 1980
- Endogenous ligands for benzodiazepine receptorsTrends in Neurosciences, 1980
- PROTEIN PHOSPHORYLATION IN SYNAPTIC MEMBRANES REGULATED BY ADENOSINE 3′:5′‐MONOPHOSPHATE: REGIONAL AND SUBCELLULAR DISTRIBUTION OF THE ENDOGENOUS SUBSTRATESJournal of Neurochemistry, 1979
- Nicotinamide is a brain constituent with benzodiazepine-like actionsNature, 1979
- Identification of inosine and hypoxanthine as endogenous inhibitors of [3H] diazepam binding in the central nervous systemLife Sciences, 1978